Add to Calendar 5/8/2019 8:00:00 AM 5/8/2019 10:00:00 AM Perfecting Your Pitch for Investors and Strategic Partners A well prepared and delivered pitch can be the key to closing a successful financing or partnership deal or the failure of your business. As we approach the June international partnering conference, #BIO2019, this is a great time for expert advice on how to perfect your pitch for maximum impact with investors or strategic partners. Our experienced panelists will discuss pitch basics plus how to customize your pitch for your audience. Get tips on how to target the right investors / partners for your startup or product and how to deliver the right value and messages that will resonate with your audience. We’ll review how to create and tell a clear, compelling story with passion and purpose that impresses even the most skeptical investors. If you’re thinking of pitching investors and partners this year, sign-up now for this don’t miss event. MassBio, 300 Technology Square 8th Fl, Cambridge, MA 02139
A well prepared and delivered pitch can be the key to closing a successful financing or partnership deal or the failure of your business. As we approach the June international partnering conference, #BIO2019, this is a great time for expert advice on how to perfect your pitch for maximum impact with investors or strategic partners. Our experienced panelists will discuss pitch basics plus how to customize your pitch for your audience. Get tips on how to target the right investors / partners for your startup or product and how to deliver the right value and messages that will resonate with your audience. We’ll review how to create and tell a clear, compelling story with passion and purpose that impresses even the most skeptical investors. If you’re thinking of pitching investors and partners this year, sign-up now for this don’t miss event.
Partner and VP of Business Development, Morse Law
John Hession is a Partner at Morse, Barnes-Brown & Pendleton, and a member of the firm’s Corporate, Venture Capital and Life Sciences practice groups. Previously, John was a co-founder of Cooley LLP's Boston office, and served as the Managing Partner of the Cooley Boston office for its first several years of operation, helping to steer and grow the Boston office from ten to seventy-plus professionals and staff. For the last thirty-five years, John has represented emerging-growth companies, as both a legal and business advisor, principally in the life sciences, medical device, hardware, software and software services sectors, as well as angels and venture capital funds in the investment process. John is also angel investor in emerging companies. John’s practice includes both start-up, emerging growth and later-stage company work, where he serves as outside general counsel. This work includes corporate governance; equity-based compensation strategies; mergers and acquisitions (representing buyers and sellers); and strategic alliances, corporate partnering, joint ventures, collaboration and development projects, and other strategic alliances involving technology transfers; as well venture capital and angel financings of companies in these sectors, representing principally companies and their management teams. John has structured and negotiated more than 400 debt and equity financings, ranging in scale from $500,000 to $250 million, and more than 350 acquisitions ranging in size from $1.0 million to $4.2 billion. During his thirty-five year career, John has represented more than 400 companies from the earliest stages of development, from cradle to culmination, from inception to liquidity (including public offering and acquisitions). John has won a number of industry awards during his career, including Best Lawyers in America, IP Stars (Managing Intellectual Property), Lawdragon 500 Leading Deal Makers, a Massachusetts Super Lawyer, and Best Lawyers in New England.